← vers les grands investisseurs
Redmile Group, LLC
gestionnaire d'actifs · portefeuille $1.49 Md · 39 positions · rapport au 30.06.2026
Positions en actions rapport pour 30.06.2026, déposé le 14.08.2026; modification — par rapport à 31.03.2026 · 39
| Société | Actions | Valeur | % du portefeuille | Variation sur le trimestre |
|---|---|---|---|---|
| Scholar Rock Holding Corp US:SRRK | 4 311 092 | $237 M | 15.92% | −4 755 529 |
| Krystal Biotech Inc US:KRYS | 632 005 | $235 M | 15.77% | −41 500 |
| Stoke Therapeutics, Inc. US:STOK | 3 945 920 | $129 M | 8.67% | −218 200 |
| Immunome Inc US:IMNM | 4 911 590 | $104 M | 6.99% | −647 295 |
| Nurix Therapeutics Inc US:NRIX | 4 073 787 | $98.8 M | 6.64% | −3 659 021 |
| Absci Corp US:ABSI | 6 739 675 | $78.1 M | 5.24% | −1 513 641 |
| Annexon, Inc. US:ANNX | 11 869 877 | $67.8 M | 4.55% | −2 679 891 |
| Regenxbio Inc US:RGNX | 4 368 804 | $52.3 M | 3.51% | — |
| Shattuck Labs Inc US:STTK | 6 892 033 | $47.8 M | 3.21% | +1 352 309 |
| Neurogene Inc US:NGNE | 1 412 199 | $44.4 M | 2.98% | −47 400 |
| Beam Therapeutics Inc. US:BEAM | 1 164 259 | $40.0 M | 2.68% | −73 400 |
| AgomAb Therapeutics NV US:AGMB | 2 733 926 | $35.5 M | 2.38% | +2 577 676 |
| Fate Therapeutics Inc US:FATE | 12 872 946 | $34.8 M | 2.33% | — |
| Ideaya Biosciences Inc US:IDYA | 640 202 | $23.9 M | 1.60% | +119 085 |
| Silence Therapeutics PLC US:SLN | 2 164 777 | $23.8 M | 1.60% | — |
| Cogent Biosciences Inc US:COGT | 503 321 | $19.5 M | 1.31% | −184 715 |
| Solid Biosciences LLC US:SLDB | 1 948 695 | $19.5 M | 1.31% | −63 200 |
| Nuvation Bio Inc US:NUVB | 3 031 009 | $17.2 M | 1.16% | −122 247 |
| Celldex Therapeutics Inc US:CLDX | 433 921 | $16.1 M | 1.08% | +172 413 |
| Climb Bio Inc US:CLYM | 1 226 330 | $16.0 M | 1.07% | nouvelle |
| Alx Oncology Holdings US:ALXO | 7 392 504 | $15.3 M | 1.03% | −571 684 |
| Biomarin Pharmaceutical Inc US:BMRN | 265 169 | $15.2 M | 1.02% | +91 310 |
| Xenon Pharmaceuticals Inc US:XENE | 229 374 | $13.8 M | 0.93% | −33 300 |
| Zymeworks Inc. US:ZYME | 491 654 | $12.9 M | 0.86% | — |
| ADC THERAPEUTICS SA CUSIP H0036K147 | 11 526 710 | $12.3 M | 0.83% | −3 943 792 |
| Aura Biosciences Inc US:AURA | 1 666 667 | $11.8 M | 0.79% | nouvelle |
| Odyssey Therapeutics, Inc. US:ODTX | 425 000 | $7.95 M | 0.53% | nouvelle |
| LIVANOVA PLC CUSIP G5509L101 | 93 154 | $7.66 M | 0.51% | −15 200 |
| ESTABLISHMENT LABS HLDGS INC CUSIP G31249108 | 88 964 | $7.63 M | 0.51% | −14 500 |
| CeriBell, Inc US:CBLL | 386 786 | $7.52 M | 0.51% | — |
Dans les entreprises de notre base de données 13
| Société | Participation | Actions | Date du rapport |
|---|---|---|---|
| Fate Therapeutics Inc | 10.74% | 12 872 946 | 2026-06-30 |
| ADC Therapeutics SA | 9.03% | 11 526 710 | 2026-06-30 |
| Neurogene Inc | 7.06% | 1 412 199 | 2026-06-30 |
| Shattuck Labs Inc | 6.87% | 6 892 033 | 2026-06-30 |
| Regenxbio Inc | 6.62% | 4 368 804 | 2026-06-30 |
| AgomAb Therapeutics NV | 5.55% | 2 733 926 | 2026-06-30 |
| Alx Oncology Holdings | 5.35% | 7 392 504 | 2026-06-30 |
| Atara Biotherapeutics Inc | 4.4% | 441 701 | 2026-06-30 |
| Immunome Inc | 4.32% | 4 911 590 | 2026-06-30 |
| Absci Corp | 3.93% | 6 739 675 | 2026-06-30 |
| Silence Therapeutics PLC | 3.6% | 2 164 777 | 2026-06-30 |
| Attovia Therapeutics, Inc. | — | — | 2026-08-06 |
| Scancell Hldgs Plc | — | 297 188 365 | 2026-07-28 |
publicité
